Protuoso Biosciences
Develops AI-enabled multifunctional biologics platform targeting cardiometabolic, oncology, and autoimmune diseases
$9.5MSeed
Role not disclosedLoading investors…
Activity from announced rounds
Develops AI-enabled multifunctional biologics platform targeting cardiometabolic, oncology, and autoimmune diseases